IDT Australia Ltd (ASX: IDT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

IDT Australia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $18.81 million
P/E Ratio 14.45
Dividend Yield 0.00%
Shares Outstanding 427.43 million
Earnings per share -0.014
Dividend per share N/A
Year To Date Return -13.73%
Earnings Yield 6.92%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

IDT Australia Ltd (ASX: IDT)
Latest News

A female scientist sits at her desk looking stressed out while working in an AnteoTech lab.
Healthcare Shares

How did ASX biotech shares perform in FY22?

Biotech certainly wasn't immune to market pressures in FY22.

Read more »

A woman screams and holds her hands up in frustration.
Healthcare Shares

Why the IDT Australia (ASX:IDT) share price is crashing 37% lower today

IDT shares are being hammered today...

Read more »

a medical person in full protective clothing holds a tray of Covid-19 vaccinations amid a haze caused by cold and ice.
Healthcare Shares

Why is the IDT (ASX:IDT) share price halted today?

Trading in the pharmaceutical manufacturer is on hold pending an announcement.

Read more »

asx share price swing represented by old lady on swing
Healthcare Shares

IDT (ASX:IDT) share price swings as CEO lauds mRNA tech in fight against Omicron

Vaccine manufacturers are racing to get ahead of the fast-mutating coronavirus.

Read more »

Starpharma share price A doctor or medical expert in COVID-19 protection flexes his muscle, indicating growth or strong share price movement in ASX medical, biotech and health companies
Share Market News

The Starpharma (ASX: SPL) share price surges on Vietnam launch

The Starpharma Holdings Limited (ASX: SPL) share price is racing ahead this morning after confirming its antiviral nasal spray will…

Read more »

A drawing of a white rocket streaking up, indicating a surging share pirce movement
Healthcare Shares

IDT Australia (ASX:IDT) share price rockets 40% on COVID vaccine update

What did IDT Australia update the ASX with?

Read more »

a medical researcher holds a vial of vaccine with a needle inserted in the top watching intently behind a mask and goggles and protective medical clothing.
Share Gainers

Here's why the IDT Australia (ASX:IDT) share price is up 75% in a month.

IDT shares have soared well into the green over the last month.

Read more »

A drawing of a rocket follows a chart up, indicating share price lift
Share Gainers

IDT Australia (ASX: IDT) share price surges 16% on vaccine government talks

IDT shares are well on the move this morning after a key update.

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Why the IDT (ASX:IDT) share price is rocketing 25% on Wednesday

The company claims it can make 100 million doses of mRNA vaccine within 18 months.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Gainers

Why the IDT Australia (ASX:IDT) share price is storming 19% higher today

This company could be about to help Australia fight back against COVID-19...

Read more »

asx share price increase represented by golden dollar sign rocketing out from white domes of lithium
Share Gainers

Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days

The IDT Australia Limited (ASX:IDT) share price was on fire again on Monday and stretched its two-day return to a…

Read more »

covid asx share price represented by man in face mask giving thumbs up
Share Market News

Why COVID-19 is launching the IDT Australia (ASX:IDT) share price 65%

The IDT Australia (ASX:ITD) share price is soaring on news the company has been asked whether it is capable of…

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
08 May 2006 $0.0350 100.00% Interim 26 May 2006
30 Sep 2005 $0.0450 100.00% Final 21 Oct 2005
08 Apr 2004 $0.0300 100.00% Interim 30 Apr 2004

IDT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About IDT Australia Ltd

IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.

IDT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
13 Mar 2026 $0.04 $0.00 0.00% 3,316 $0.04 $0.04 $0.04
12 Mar 2026 $0.04 $0.00 0.00% 65,512 $0.04 $0.04 $0.04
11 Mar 2026 $0.05 $0.00 0.00% 10,335 $0.05 $0.05 $0.05
10 Mar 2026 $0.05 $0.00 0.00% 12,535 $0.05 $0.05 $0.05
09 Mar 2026 $0.05 $0.00 0.00% 57,103 $0.05 $0.05 $0.05
06 Mar 2026 $0.05 $0.00 0.00% 111,933 $0.05 $0.05 $0.04
05 Mar 2026 $0.05 $0.00 0.00% 140,827 $0.05 $0.05 $0.05
04 Mar 2026 $0.05 $0.00 0.00% 138,862 $0.05 $0.05 $0.05
03 Mar 2026 $0.05 $0.00 0.00% 286,751 $0.05 $0.05 $0.05
27 Feb 2026 $0.05 $0.00 0.00% 29,145 $0.05 $0.05 $0.05
25 Feb 2026 $0.05 $0.00 0.00% 7,826 $0.05 $0.05 $0.05
24 Feb 2026 $0.05 $0.00 0.00% 214,058 $0.05 $0.05 $0.05
23 Feb 2026 $0.05 $0.00 0.00% 56,198 $0.05 $0.05 $0.05
20 Feb 2026 $0.05 $0.00 0.00% 163,556 $0.05 $0.05 $0.05
19 Feb 2026 $0.05 $0.00 0.00% 909,570 $0.05 $0.05 $0.05
18 Feb 2026 $0.05 $0.01 23.26% 839,788 $0.05 $0.05 $0.05
17 Feb 2026 $0.04 $0.00 0.00% 513,991 $0.05 $0.05 $0.04
16 Feb 2026 $0.05 $0.00 0.00% 254,160 $0.05 $0.05 $0.04

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
18 Feb 2026 Mark Simari Buy 501,936 $24,092
On-market trade.
04 Dec 2025 Geoffrey Sam Buy 98,039 $5,098
On-market trade.
10 Apr 2025 Geoffrey Sam Buy 228,015 $22,801
On-market trade.
09 Apr 2025 Geoffrey Sam Buy 20,617 $2,020
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Mark Anthony Simari Non-Executive DirectorNon-Executive Chairman Oct 2022
Mr Simari is an experienced and accomplished professional in the health industry and has over 15 years of Board experience in a diverse range of organizations. He was involved in Paragon Care becoming an independent healthcare supplier in the Australian and New Zealand Markets, creating a healthcare platform spanning across capital equipment, consumables, devices and service and maintenance. Non-Executive Chairman of the Board and a Member of the Risk Committee.
Mr Geoffrey Joseph Sam Non-Executive Director Oct 2022
Mr Sam is currently the Chairperson and has also held previous independent Non-executive Board positions with listed companies Money 3 Ltd, Hutchinsons Childcare Services Ltd and was Managing Director of Nova Health Ltd. He is the Co-Founder and Board member of Healthe Care Australia Pty Ltd, a privately owned health care company comprising a portfolio of 18 hospitals. He is Chair of the Risk Committee.
Dr Jane Ryan Non-Executive Director Jan 2022
Dr Ryan has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the United States and United Kingdom. Throughout her career, she has led many fundraising campaigns and licensing initiatives including the winning of a $230 million US Government contract. He is a Member of the Risk Committee.
Mr Mark Andrew Licciardo Company Secretary Oct 2022
-
Mr Paul Joseph Mcdonald Chief Executive Officer Sep 2022
-
Paul Joseph Mcdonald Chief Executive Officer
-
Vasanthakumar Chief Financial Officer
-
J Sosic Chief Operating Officer
-
Mark Andrew Licciardo Company Secretary
-
M Flanders Director of Commercial & Business Development
-
M Thompson Director of Commercial & Business Development
-
R Caunce Director of Quality
-
P Coutts Head of People & Safety
-
P Thiyageas Quality Director
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
One Managed Invt Funds Ltd Sandon Capital Inv Ltd A/C 48,283,127 11.39%
HSBC Custody Nominees (Australia) Limited 35,934,779 8.47%
Citicorp Nominees Pty Limited 33,220,721 7.83%
One Fund Services Ltd Sandon Capital Activist A/C 29,043,707 6.85%
UBS Nominees Pty Ltd 28,827,545 6.80%
Mr Anthony John Huntley 11,600,000 2.74%
Mr Robert Darius Fraser Fraser Family A/C 11,278,752 2.66%
Keiser Investments Pty Ltd Gann Family Retirement A/C 7,435,523 1.75%
On On For Don Pty Ltd Mac Family A/C 6,700,000 1.58%
Picherit'S Farm Pty Ltd Huntley Super Fund A/C 6,500,000 1.53%
Invia Custodian Pty Limited Graeme Leslie Blackman A/C 6,029,710 1.42%
J P Morgan Nominees Australia Pty Limited 5,078,928 1.20%
Mr Edmond Wing Kin Cheung & Mrs Eliza Siu Ling Cheung Edmond & Eliza S/F A/C 4,929,147 1.16%
Rossbow Pty Ltd Andrew Macpherson Tdt A/C 4,050,000 0.96%
Ms Melissa Mary Stephens 4,000,000 0.94%
Laicos Securities Pty Ltd 4,000,000 0.94%
Mr Alistair David Strong 3,880,352 0.92%
Luton Pty Ltd 3,638,889 0.86%
Jasbaat Super Pty Ltd 3,490,663 0.82%
Invia Custodian Pty Limited Paulene Blackman A/C 3,457,737 0.82%

Profile

since

Note